Molecular detection of fluoroquinolone resistance-associated gyrA mutations in ofloxacin-resistant clinical isolates of Mycobacterium tuberculosis from Iran and Belarus

被引:5
|
作者
Arjomandzadegan, Mohammad [1 ]
Titov, Leonid [2 ]
Farnia, Parissa [3 ]
Owlia, Parviz [4 ]
Ranjbar, Reza [5 ]
Sheikholeslami, Fatemeh [3 ]
Surkova, Larissa [6 ]
机构
[1] Arak Univ Med Sci, IDRC, Basij Sq, Arak 3133705, Iran
[2] Res Inst Epidemiol & Microbiol, Minsk, BELARUS
[3] Shahid Beheshti Univ Med Sci, NRITLD, MRC, Tehran, Iran
[4] Shahed Univ, Mol Microbiol Res Ctr, Tehran, Iran
[5] Baqiyatallah Univ Med Sci, Mol Biol Res Ctr, Tehran, Iran
[6] Inst Pulmonol & Phthisiol, Minsk, BELARUS
关键词
gyrA; Mutation; Mycobacterium tuberculosis; Ofloxacin; Resistance;
D O I
10.1016/j.ijmyco.2016.07.004
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Objective/background: Detection of mutations in the quinolone resistance-determining region (QRDR) of the gyrA gene could determine resistance to fluoroquinolone antituberculosis drugs. The aim of this study was to detect mutations in QRDRs. Methods: From 184 clinical isolates of Mycobacterium tuberculosis, ofloxacin resistance was proven in 42 isolates using the proportion method. The molecular basis of resistance to ofloxacin were investigated by the determination of mutations in the QRDR region of the gyrA gene. Extracted DNA fragments of 194 bp from the gyrA gene were amplified and an automatic DNA sequencer was used for the sequencing process. Results: Molecular genetic analysis of 42 resistant M. tuberculosis strains demonstrated that they belong to Principal Genetic Group (PGG) 1 in 19 cases (45.2 +/- 10.9%), to PGG2 in 15 cases (35.7 +/- 10.5%), and to PGG3 in eight cases (19.0 +/- 8.4%). Isolates from PGG1 were dominant among resistant isolates (P<.05). It was found that 24 (57%) resistant isolates carried mutations at codon 94 with five different amino acid changes: D94A (n = 11), D94G (n = 3), D94T (n = 4), D94A (n = 4), and D94Y (n = 2). The remaining 18 (43%) isolates had mutations in codon A90V (GCG -> GTG) and S91P (TCG -> CCG). Five isolates had two mutations in codons 90 and 94. There was no difference between mutations at these two codons in resistant isolates of the two countries (P<.001). There was no polymorphism observed in codon 95 in any of the ofloxacin-susceptible isolates. Conclusion: It was concluded that the determination of nucleotide sequences of QRDRs can be used as a molecular test for the rapid detection of ofloxacin resistance. Furthermore, frequencies in gyrA codons in Belarus and Iran were similar, therefore it is not of geographical concern for the two countries. (C) 2016 Asian-African Society for Mycobacteriology. Production and hosting by Elsevier Ltd.
引用
收藏
页码:299 / 305
页数:7
相关论文
共 50 条
  • [1] GYRA AND GYRB MUTATIONS IN OFLOXACIN-RESISTANT MYCOBACTERIUM TUBERCULOSIS CLINICAL ISOLATES IN THAILAND
    Pitaksajjakul, Pannamthip
    Worakhunpiset, Suwalee
    Chaiprasert, Angkana
    Boonyasopun, Jirakarn
    Ramasoota, Pongrama
    [J]. SOUTHEAST ASIAN JOURNAL OF TROPICAL MEDICINE AND PUBLIC HEALTH, 2011, 42 (05) : 1163 - 1167
  • [2] gyrA of ofloxacin-resistant clinical isolates of Mycobacterium tuberculosis from Hong Kong
    Williams, KJ
    Chan, R
    Piddock, LJV
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1996, 37 (05) : 1032 - 1034
  • [3] First report of molecular detection of fluoroquinolone resistance- associated gyrA mutations in multidrug-resistant clinical Mycobacterium tuberculosis isolates in Kuwait
    Al-Mutairi N.M.
    Ahmad S.
    Mokaddas E.
    [J]. BMC Research Notes, 4 (1)
  • [4] Comparison of gyrA gene mutations between laboratory-selected ofloxacin-resistant Mycobacterium tuberculosis strains and clinical isolates
    Sun, Zhaogang
    Zhang, Jianyuan
    Zhang, Xuxia
    Wang, Sumin
    Zhang, Ying
    Li, Chuanyou
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2008, 31 (02) : 115 - 121
  • [5] Characterization of gyrA and gyrB mutations associated with fluoroquinolone resistance in Mycobacterium tuberculosis isolates from Morocco
    Chaoui, Imane
    Oudghiri, Amal
    El Mzibri, Mohammed
    [J]. JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE, 2018, 12 : 171 - 174
  • [6] Prevalence of gyrA and B gene mutations in fluoroquinolone-resistant and -sensitive clinical isolates of Mycobacterium tuberculosis and their relationship with MIC of ofloxacin
    Pooja Singh
    Amita Jain
    Pratima Dixit
    Shantanu Prakash
    Indu Jaiswal
    Vimala Venkatesh
    Mastan Singh
    [J]. The Journal of Antibiotics, 2015, 68 : 63 - 66
  • [7] Prevalence of gyrA and B gene mutations in fluoroquinolone-resistant and -sensitive clinical isolates of Mycobacterium tuberculosis and their relationship with MIC of ofloxacin
    Singh, Pooja
    Jain, Amita
    Dixit, Pratima
    Prakash, Shantanu
    Jaiswal, Indu
    Venkatesh, Vimala
    Singh, Mastan
    [J]. JOURNAL OF ANTIBIOTICS, 2015, 68 (01): : 63 - 66
  • [8] Characterization of gyrA and gyrB mutations and fluoroquinolone resistance in Mycobacterium tuberculosis clinical isolates from Hubei Province, China
    Chen, Jun
    Chen, Zhifei
    Li, Yuanyuan
    Xia, Wei
    Chen, Xi
    Chen, Tian
    Zhou, Liping
    Xu, Bin
    Xu, Shunqing
    [J]. BRAZILIAN JOURNAL OF INFECTIOUS DISEASES, 2012, 16 (02): : 136 - 141
  • [9] RESEARCH ON THE CROSS-RESISTANCE, GYRA GENE MUTATION AND STABILITY OF LABORATORY-SELECTED, OFLOXACIN-RESISTANT MYCOBACTERIUM TUBERCULOSIS STRAINS AND CLINICAL ISOLATES IN VITRO
    Yang, H.
    Hu, Z.
    Sha, W.
    Wang, J.
    Lu, J.
    Cui, Z.
    Li, F.
    Huang, X.
    Xiao, H.
    [J]. RESPIROLOGY, 2011, 16 : 83 - 84
  • [10] Frequency and Geographic Distribution of gyrA and gyrB Mutations Associated with Fluoroquinolone Resistance in Clinical Mycobacterium tuberculosis Isolates: A Systematic Review
    Avalos, Elisea
    Catanzaro, Donald
    Catanzaro, Antonino
    Ganiats, Theodore
    Brodine, Stephanie
    Alcaraz, John
    Rodwell, Timothy
    [J]. PLOS ONE, 2015, 10 (03):